Lori Getts

Professional Overview
Lori Getts is an experienced biopharmaceutical executive with a strong focus on process development and preclinical production. As the Head of Process Development and Preclinical Production, and Co-Founder at Code BioTherapeutics, she leverages her extensive expertise in leading innovative projects and driving the advancement of novel therapeutic candidates.

Experience Summary

Current Role
In her current role as Head of Process Development and Preclinical Production, and Co-Founder at Code BioTherapeutics, Lori is responsible for overseeing the entire process development lifecycle, from early-stage research to scaled-up preclinical production. She plays a pivotal role in streamlining manufacturing processes, ensuring quality control, and supporting the successful advancement of Code BioTherapeutics' pipeline.

Career Progression
Prior to her current position, Lori held various leadership roles at Genisphere LLC, where she progressed from Manager of Manufacturing to Vice President of Preclinical and Process Development. During her tenure, she demonstrated a strong track record of driving operational excellence, improving manufacturing efficiency, and contributing to the development of numerous therapeutic candidates.

Academic Background
Lori holds a relevant educational background, though the specific details were not provided in the information given.

Areas of Expertise
Lori's expertise spans a range of critical areas in the biopharmaceutical industry, including process development, preclinical production, manufacturing optimization, quality assurance, and cross-functional collaboration. She has a proven ability to navigate complex regulatory requirements and effectively translate research findings into scalable production processes.

Professional Impact
Throughout her career, Lori has made significant contributions to the advancement of biopharmaceutical therapies. Her work has facilitated the successful progression of multiple drug candidates through the preclinical stage, paving the way for their transition into clinical trials. Lori's leadership and innovative approach have earned her recognition within the industry and positioned her as a valuable asset to the organizations she has served.

Conclusion
With her extensive experience and demonstrated success in process development and preclinical production, Lori Getts is well-positioned to drive the continued growth and success of Code BioTherapeutics. Her expertise, coupled with her entrepreneurial mindset and commitment to advancing novel therapies, make her a valuable addition to the biopharmaceutical industry.